Who are Xueshuantong lyophilized powder's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Standard treatment+Xiyanping injection, Erigeron breviscapus injection, HUACHANSU PIAN.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/xueshuantong-lyophilized-powder.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Xueshuantong lyophilized powder — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Xueshuantong lyophilized powder (Xueshuantong lyophilized powder) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese medicine extract. Area: Cardiovascular; Neurology.

marketed Traditional Chinese medicine extract Cardiovascular; Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Xueshuantong lyophilized powder (Xueshuantong lyophilized powder) — Dongzhimen Hospital, Beijing. Xueshuantong is a traditional Chinese medicine-derived lyophilized powder that promotes blood circulation and removes blood stasis to improve microvascular perfusion.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Xueshuantong lyophilized powder TARGET	Xueshuantong lyophilized powder	Dongzhimen Hospital, Beijing	marketed	Traditional Chinese medicine extract
Standard treatment+Xiyanping injection	Standard treatment+Xiyanping injection	Jiangxi Qingfeng Pharmaceutical Co. Ltd.	marketed	Traditional Chinese medicine extract
Erigeron breviscapus injection	Erigeron breviscapus injection	Guangzhou University of Traditional Chinese Medicine	marketed	Traditional Chinese medicine extract; antiplatelet/microcirculation enhancer
HUACHANSU PIAN	HUACHANSU PIAN	Beijing Shenogen Biomedical Co., Ltd	phase 3	Traditional Chinese medicine extract; natural product

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese medicine extract class)

Dongzhimen Hospital, Beijing · 1 drug in this class
Jiangxi Qingfeng Pharmaceutical Co. Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Xueshuantong lyophilized powder — Competitive Intelligence Brief. https://druglandscape.com/ci/xueshuantong-lyophilized-powder. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab